Clinical Trials Browser

Phase 1 × Ovarian Neoplasms × Lapatinib × Clear all

Ovarian Neoplasms

NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

NCT00317434 2009-12-15

Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer

Phase 1 Terminated

12 enrolled

Gynecologic

Ovarian Neoplasms

Clinical Trials

Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Maximum Tolerated Dose of Lapatinib When Given With Carboplatin for Recurrent Ovarian Cancer